Session » Metabolic and Crystal Arthropathies - Poster II: Epidemiology and Mechanisms of Disease
- 9:00AM-11:00AM
-
Abstract Number: 2285
12/15-Lipoxygenase Inhibition By ML351 Protects Against Uric Acid Crystal-Induced Acute Arthritis in Mice
- 9:00AM-11:00AM
-
Abstract Number: 2295
A Non-Linear Relationship Between Physical Activity and Serum Uric Acid Concentrations: Nhanes 2003-2004
- 9:00AM-11:00AM
-
Abstract Number: 2286
Bioresponsive Glucocorticoid-Loaded Microparticles to Prevent Acute Gout Flares
- 9:00AM-11:00AM
-
Abstract Number: 2293
Cardiometabolic Risk and Subclinical Urate Deposits in Patients with Symptomatic Hyperuricemia and Metabolic Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2290
Crystal-Proven Gout and Disease Severity Factors Influencing the Prevalence of Cardiovascular Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2292
Decreased Endothelial and Smooth Muscle Responsiveness in the Vasculature of Gout Patients Compared with Healthy Controls: Relationship Between Flow- and Nitrate-Mediated Dilation, Serum Urate and CRP
- 9:00AM-11:00AM
-
Abstract Number: 2304
Decreased Occurrence of Colon Cancer Among Gout Patients: Assessment By Physician Diagnosis and Colonoscopy
- 9:00AM-11:00AM
-
Abstract Number: 2284
Differential Effect of MSU-Crystal Induced Inflammation on Macrophage Polarization
- 9:00AM-11:00AM
-
Abstract Number: 2274
Evidence of Phospho-Degron Regulating Expression of Urate Secretory Transporter ABCG2
- 9:00AM-11:00AM
-
Abstract Number: 2277
Exon Sequencing Reveals a Significant Burden of Non-Synonymous Variants in Both SLC22A11 (OAT4) and SLC22A12 (URAT1) in European Hyperuricemic Individuals
- 9:00AM-11:00AM
-
Abstract Number: 2282
Ferritin Levels Are Associated with Urate and Gout – a Role for Iron Metabolism in Gout ?
- 9:00AM-11:00AM
-
Abstract Number: 2275
Genome-Wide Association Study of Gout in New Zealand Polynesian People
- 9:00AM-11:00AM
-
Abstract Number: 2301
Gout and Subsequent Risk of Incident Erectile Dysfunction: A Population-Based Cohort Study from the United Kingdom
- 9:00AM-11:00AM
-
Abstract Number: 2291
Impact of Plasma Urate and Tophaceous Burden on Inflammatory Biomarkers of Cardiovascular Disease
- 9:00AM-11:00AM
-
Abstract Number: 2306
Improving Predictive Value of Gout Case Definitions in Electric Medical Records Utilizing Natural Language Processing: a Novel Informatics Approach
- 9:00AM-11:00AM
-
Abstract Number: 2298
Incident Risk of Acute Gout Among Active Smokers: Data from Nationwide Inpatient Sample
- 9:00AM-11:00AM
-
Abstract Number: 2270
Inflammasome/IL-1β Activation Induced By Calcium Pyrophosphate Dihydrate Crystals Is Mainly Driven By a P2X7 Receptor-Independent Potassium Efflux
- 9:00AM-11:00AM
-
Abstract Number: 2288
Inflammatory Status and Serum Uric Acid Determine High-Density Lipoprotein Cholesterol Levels in a Non-Rheumatic Population
- 9:00AM-11:00AM
-
Abstract Number: 2305
Mapping the Topography of Gout Flares: Solutions for Flare Reporting in Gout Clinical Trials
- 9:00AM-11:00AM
-
Abstract Number: 2280
Monosodium Urate Crystal-Induced Inflammation Promotes Osteocyte Expression of Pro-Resorptive and Inflammatory Mediators: Implications for Erosive Gout
- 9:00AM-11:00AM
-
Abstract Number: 2281
Monosodium Urate Monohydrate (MSU) Crystals Induces Cartilage Degeneration By Accelerating Hypertrophy and Mineralization.
- 9:00AM-11:00AM
-
Abstract Number: 2271
Mutation in Osteoprotegerin Gene: Early-Onset Osteoarthritis and Chondrocalcinosis in a US Family of Italian/German Ancestry
- 9:00AM-11:00AM
-
Abstract Number: 2289
Obesity and Echocardiographic Changes in the Different Stages of Gout
- 9:00AM-11:00AM
-
Abstract Number: 2276
Pleiotropic Effect of ABCG2 in Gout
- 9:00AM-11:00AM
-
Abstract Number: 2278
Precision of Gout Definitions for Population-Based Genetic Studies: Analysis of the UK Biobank
- 9:00AM-11:00AM
-
Abstract Number: 2299
Predictors of Mortality in People with Recent Onset of Gout: A Prospective Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 2269
Proteinaceous Amorphous Calcium Carbonates As a Novel Family of Crystals in Synovial Fluid from Symptomatic Joints
- 9:00AM-11:00AM
-
Abstract Number: 2287
Serum Urate and Its Association with Endothelial Dysfunction in Young Adults
- 9:00AM-11:00AM
-
Abstract Number: 2297
Serum Urate and Its Association with Race in Young Adults: Baseline Analysis from a Randomized Clinical Trial
- 9:00AM-11:00AM
-
Abstract Number: 2279
Soluble Urate: A Direct Mediator of Bone Turnover?
- 9:00AM-11:00AM
-
Abstract Number: 2283
Suppression of Monosodium Urate (MSU) Crystals-Induced Inflammatory Response By Inhibiting TGF-β Activated Kinase 1 (TAK1)
- 9:00AM-11:00AM
-
Abstract Number: 2296
The Influence of Androgen Deprivation Therapy on Serum Uric Acid Level
- 9:00AM-11:00AM
-
Abstract Number: 2272
The Influence of Genetic Variants on Renal Uric Acid Excretion in Response to Frusemide
- 9:00AM-11:00AM
-
Abstract Number: 2300
Tophaceous Gout and the Risk of Mortality: A General Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 2273
Trans-Ancestral Meta-Analysis Identifies Nine New Loci Associated with Serum Uric Acid Concentrations
- 9:00AM-11:00AM
-
Abstract Number: 2303
Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada from 2000-2011
- 9:00AM-11:00AM
-
Abstract Number: 2294
Uric Acid Production and Blood Pressure: The Role of Uric Acid Concentration As Well As Uric Acid Production